Furthermore, most of the CD4+ EM cells could be identified as CCR5-expressing Th1 cells in a subgroup of patients analyzed by a second antibody panel (Supplementary Figure S5), which are known to be primarily responsible for disease progression in LN (30–32). This evidence concerns the gene CCR5 and lobular neoplasia.